Keyphrases
Cell Sensitivity
100%
Candidate Evaluation
100%
Cancer Cells
100%
Inhibitor Treatment
100%
Polymerase
100%
PARP-1 Inhibitor
100%
Cell Resistance
100%
Ribose
100%
53BP1
42%
BRCA1, BRCA2
28%
Promising Treatment
14%
DNA Damage Response Pathway
14%
Acquired Resistance
14%
Human Cell Lines
14%
RAD51
14%
In Cancer
14%
Focus Formation
14%
Breast Cancer Cells
14%
Pancreas
14%
DNA Repair
14%
Aberrations
14%
Response Predictors
14%
Resistance Mechanisms
14%
Prostate
14%
P53 Status
14%
Predictive Biomarker
14%
Genetic Determinants
14%
Repair Pathway
14%
Vulnerability
14%
Biomarkers of Response
14%
Camptothecin
14%
MRE11-RAD50-NBS1 Complex
14%
Selective Vulnerability
14%
Cancer Therapy
14%
Breast Carcinoma
14%
Homologous Recombination
14%
Surrogate Marker
14%
Cellular Response
14%
Lentivirus
14%
Multidrug Resistance
14%
Short Hairpin RNA (shRNA)
14%
PARP Inhibitor (PARPi)
14%
Tumor
14%
Colon
14%
Ionizing Radiation
14%
Breast Cancer Susceptibility Gene 1 (BRCA1)
14%
Medicine and Dentistry
Polymerase
100%
Cancer Cell
100%
Biological Marker
100%
Poly ADP Ribose Polymerase
100%
BRCA1
37%
Neoplasm
12%
Ionizing Radiation
12%
Protein P53
12%
Cell Line
12%
Carcinoma
12%
DNA Damage Response
12%
Camptothecin
12%
Disease Marker
12%
BRCA2
12%
Multidrug Resistance
12%
DNA Repair
12%
Short Hairpin RNA
12%
Colon
12%
Cancer Therapy
12%
Triple Negative Breast Cancer
12%
Malignant Neoplasm
12%
Homologous Recombination
12%
Breast Cancer
12%
Pharmacology, Toxicology and Pharmaceutical Science
Lentivirus
20%
Triple Negative Breast Cancer
20%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
20%
Biochemistry, Genetics and Molecular Biology